{"kind":"price","itemId":"IVF-1CYCLE","country":"BE","sourceId":"data6-be-inami-ivf","sourceTier":"official","sourceUrl":"https://www.riziv.fgov.be/SiteCollectionDocuments/troubles_fertilite_feminine.pdf","retrievedAt":"2026-10-15T06:06:44.574Z","fileSha256":"447e1962f9a435489a7d1a2a4c3eaf7e186c38572a7bc049066891c0db231806","period":"2026-10-15","periodBasis":"Official currently linked information sheet, verified on retrieval date; tariff amount effective from 2013-10-01 per INAMI circular OA 2014/23.","effectiveFrom":"2013-10-01","value":{"amount":920,"currency":"EUR","statistic":"fixed"},"payerContext":"public_tariff","scope":"procedure","component":"PMA1: medicines only per completed IVF cycle, with or without ICSI; total statutory pharmaceutical forfait including beneficiary copay","procedureCode":{"system":"INAMI/RIZIV pseudocode","code":"757293"},"tariffCode":"PMA1","procedureDescription":"Forfait PMA1 pour spécialités pharmaceutiques par cycle complet de FIV avec ou sans ICSI","comparable":false,"verificationLevel":2,"license":"INAMI reuse with source attribution","licenseUrl":"https://www.riziv.fgov.be/fr/disclaimer","attribution":"Source: INAMI / RIZIV, Médicaments utilisés dans les troubles de la fertilité; circulaire OA 2014/23.","comparabilityNotes":"Pharmaceutical component only, not a total IVF package, clinic quote or patient payable amount. No other component is added. Reimbursement requires prior insurer medical authorization and conditions described by INAMI. Primary sheet is undated but currently linked by INAMI; the unchanged 920-euro amount is corroborated by the dated 2013 amendment, which superseded the 2009 1,073-euro amount. Retrieval date is not an invented 2026 tariff effective date.","evidence":{"locator":"PDF page 1, Le forfait ‘FIV’, first sentence; PMA1 total including ticket modérateur","verbatim":"Un forfait PMA1 de 920 euros (ticket modérateur compris) est attribué, par cycle complet, pour le coût des spécialités pharmaceutiques utilisées dans le cadre d’une fécondation in vitro (avec ou sans ICSI – injection intra-cytoplasmique d’un spermatozoïde)."},"supportingEvidence":[{"sourceUrl":"https://webappsa.riziv-inami.fgov.be/Nomen/fr/757293/pdf/8859","fileSha256":"63db4446ae78eeac877b8edfe95e3aa43100214a4e13ddc99e5ac140893c6836","locator":"Circular OA 2014/23, PDF page 2; effective date paragraph and PMA1 row, Forfait total column","verbatim":"Une modification de l’arrêté royal du 6 octobre 2008 instaurant un remboursement forfaitaire pour les spécialités pharmaceutiques utilisées dans les traitements de l’infertilité féminine est entrée en vigueur le 1er octobre 2013 (MB du 20 septembre 2013). Elle modifie les montants des forfaits PMA1, PMA2 et PMA3, sans modifier le montant dû par le patient. Vous trouverez ci-dessous les montants mis à jour, ainsi que les pseudocodes correspondants.\nPMA1                 757293                        920     865,10           54,90               883,36            36,64"}],"id":"65d15e709f3d6b63408e8788df129976721a97082984d0577cbd12565f1bd84f","providerKey":null,"unit":"EUR","amount":920,"usd":1031.136,"fx":{"rateToUsd":1.1208,"date":"2026-10-15","source":"ECB/Frankfurter"},"excluded":false,"exclusionReason":null}